PT

Portola Pharmaceuticals

- NASDAQ:PTLA
  • Portola Pharmaceuticals develops therapeutics for acute and chronic cardiovascular, and autoimmune and inflammatory diseases.

  • Locations

    • South San Francisco CA

  • Total Funding (USD)

    149.0 million

  • Industries

    Mobile Apps, Cyber Security

  • Security

    Type: ORD
    CUSIP: 737010108
    ISIN: US7370101088
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo